Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2025-12-26 @ 12:57 AM
Study NCT ID:
NCT00842959
Status:
COMPLETED
Last Update Posted:
2011-06-16
First Post:
2009-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX
Sponsor:
Carl Zeiss Meditec AG
Organization:
Study Overview
Official Title:
Check of Optical Features and Accuracy of the Zeiss ZO Lens of the Company Carl Zeiss Meditec After Selection and Calculation With OKULIX
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ZO Okulix
Brief Summary:
It is planned to implant the intraocular lenses XL Stabi ZO and Invent ZO into the eyes of patients for whom a cataract operation is medically indicated. The lenses are marketed and CE certified. Their implantation is clinical routine.
In the trial the accuracy of prediction of target refraction and the difference between calculated and measured contrast vision will be examined for both lens types.
In the trial the accuracy of prediction of target refraction and the difference between calculated and measured contrast vision will be examined for both lens types.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: